A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma.
Mohammed TA; Holen KD; Jaskula-Sztul R; Mulkerin D; Lubner SJ; Schelman WR; Eickhoff J; Chen H; Loconte NK; The Oncologist, 2011, vol. 16, issue 6, p 835, ISSN 1549490x. ISBN 1549490x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef